nContact EPi-Sense device receives CE mark
nContact has received CE mark approval for its fourth generation EPi-Sense guided-coagulation device with VisiTrax for the treatment of cardiac arrhythmias, including atrial fibrillation.
Say something
nContact has received CE mark approval for its fourth generation EPi-Sense guided-coagulation device with VisiTrax for the treatment of cardiac arrhythmias, including atrial fibrillation.
Ventus Medical has received European CE mark approval for its Provent sleep apnoea therapy.
IntraPace has received European CE mark approval for its abiliti system as a treatment for obesity.